BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 32286715)

  • 21. Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women.
    Jahromi BN; Dabbaghmanesh MH; Bakhshaie P; Parsanezhad ME; Anvar Z; Alborzi M; Zarei A; Bakhshaei M
    Taiwan J Obstet Gynecol; 2018 Aug; 57(4):555-559. PubMed ID: 30122578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adiponectin and resistin serum levels in women with polycystic ovary syndrome during oral glucose tolerance test: a significant reciprocal correlation between adiponectin and resistin independent of insulin resistance indices.
    Lewandowski KC; Szosland K; O'Callaghan C; Tan BK; Randeva HS; Lewinski A
    Mol Genet Metab; 2005 May; 85(1):61-9. PubMed ID: 15862282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin resistance in polycystic ovary syndrome: hyperandrogenemia versus normoandrogenemia.
    Yildiz BO; Gedik O
    Eur J Obstet Gynecol Reprod Biol; 2001 Dec; 100(1):62-6. PubMed ID: 11728659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
    Li X; Lin JF
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polycystic ovary syndrome and abnormalities in glucose tolerance.
    Bhattacharya SM
    Int J Gynaecol Obstet; 2009 Apr; 105(1):29-31. PubMed ID: 19155002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma total oxidant and antioxidant status after oral glucose tolerance and mixed meal tests in patients with polycystic ovary syndrome.
    Kucukaydın Z; Duran C; Basaran M; Camlica F; Erdem SS; Basaran A; Kutlu O; Burnik FS; Elmas H; Gonen MS
    J Endocrinol Invest; 2016 Oct; 39(10):1139-48. PubMed ID: 27300033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
    Wang L; Lv S; Li F; Yu X; Bai E; Yang X
    Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
    [No Abstract]   [Full Text] [Related]  

  • 29. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of metformin by employing 2-hour postload insulin for measuring insulin resistance in Taiwanese women with polycystic ovary syndrome.
    Ou HT; Chen PC; Wu MH
    J Formos Med Assoc; 2017 Feb; 116(2):80-89. PubMed ID: 27131512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vigorous exercise is associated with superior metabolic profiles in polycystic ovary syndrome independent of total exercise expenditure.
    Greenwood EA; Noel MW; Kao CN; Shinkai K; Pasch LA; Cedars MI; Huddleston HG
    Fertil Steril; 2016 Feb; 105(2):486-93. PubMed ID: 26551442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin secretion in women who have polycystic ovary syndrome and carry the Gly972Arg variant of insulin receptor substrate-1 in response to a high-glycemic or low-glycemic carbohydrate load.
    Sir-Petermann T; Angel B; Maliqueo M; Santos JL; Riesco MV; Toloza H; Pérez-Bravo F
    Nutrition; 2004 Oct; 20(10):905-10. PubMed ID: 15474880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of the metabolic syndrome in Asian women with polycystic ovary syndrome: using the International Diabetes Federation criteria.
    Weerakiet S; Bunnag P; Phakdeekitcharoen B; Wansumrith S; Chanprasertyothin S; Jultanmas R; Thakkinstian A
    Gynecol Endocrinol; 2007 Mar; 23(3):153-60. PubMed ID: 17454169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Higher metabolic risk with National Institutes of Health versus Rotterdam diagnostic criteria for polycystic ovarian syndrome in Turkish women.
    Anaforoglu I; Algun E; Incecayir O; Ersoy K
    Metab Syndr Relat Disord; 2011 Oct; 9(5):375-80. PubMed ID: 21657888
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Obesity-related lipid profile and altered insulin incretion in adolescents with polycystic ovary syndrome.
    Fulghesu A; Magnini R; Portoghese E; Angioni S; Minerba L; Melis GB
    J Adolesc Health; 2010 May; 46(5):474-81. PubMed ID: 20413084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls.
    Douglas CC; Norris LE; Oster RA; Darnell BE; Azziz R; Gower BA
    Fertil Steril; 2006 Aug; 86(2):411-7. PubMed ID: 16762348
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homeostatic Model Assessment for Insulin Resistance (HOMA-IR): A Better Marker for Evaluating Insulin Resistance Than Fasting Insulin in Women with Polycystic Ovarian Syndrome.
    Majid H; Masood Q; Khan AH
    J Coll Physicians Surg Pak; 2017 Mar; 27(3):123-126. PubMed ID: 28406767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation of plasma omentin-1 with insulin resistance in non-obese polycystic ovary syndrome.
    Yang HY; Ma Y; Lu XH; Liang XH; Suo YJ; Huang ZX; Lu DC; Qin YF; Luo ZJ
    Ann Endocrinol (Paris); 2015 Oct; 76(5):620-7. PubMed ID: 26514948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
    Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
    Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.